首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmaceutical medicine

缩写:

ISSN:1178-2595

e-ISSN:1179-1993

IF/分区:4.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引316条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Judith Nelissen,Angela Williams,Cerise James et al. Judith Nelissen et al.
An integrated evidence generation plan (IEGP) can transform the effectiveness of how pharmaceutical companies demonstrate the value of new therapies. Medical Affairs professionals are uniquely positioned to lead and shape an IEGP, leveragin...
Giacomo Vitturi,Luca Piccoli,Andrea Spini et al. Giacomo Vitturi et al.
Background and objectives: Tumor neurosis factor alpha (TNFα) inhibitors are widely used for the treatment of immune-mediated inflammatory diseases. Following the patent expiration of infliximab, etanercept, and adalimum...
Sangeeta Sharma,Parminder Gautam,Deepika Sharma et al. Sangeeta Sharma et al.
Medication safety is a critical component of patient care, yet fragmented regulations, under-reporting of adverse events, and resource constraints continue to pose risks in India and Southeast Asia. Addressing these challenges requires syst...
Stéphanie Légaré,Sherry Lin,Sarah Vahey et al. Stéphanie Légaré et al.
Background: Lupus erythematosus is a heterogeneous autoimmune disease with manifestations ranging from skin-limited forms to severe systemic disease. Despite the high prevalence of skin symptoms among lupus participants, ...
Thu Anh Do,Tung Hoang Thu Anh Do
Health economic evaluation (HEE) guidelines play an important role in health technology assessment (HTA) by supporting the consistent and transparent use of economic evidence in decision making. As countries continue updating their guidelin...
Chad Rieger,Judith A Dean,Gregory Merlo et al. Chad Rieger et al.
Biosimilar medicines have the potential to reduce costs and expand patient access, yet uptake rate remains uneven world-wide. This policy review will (1) evaluate and compare biosimilar medicine uptake and policy frameworks across eight cou...
Aidan W Leffler,Graham J Leffler,Marielle G Contesse Aidan W Leffler
Background and objectives: While there has been an increase in Duchenne muscular dystrophy (DMD) clinical trials over the last couple of decades, there is still no cure. Many individuals with DMD spend much of their lives...
Inga Dammann-Bawadkji,F Markus Leweke,Cathrin Rohleder Inga Dammann-Bawadkji
Schizophrenia is a complex neuropsychiatric disorder manifesting with diverse positive and negative symptoms as well as cognitive impairments. Current antipsychotics primarily address positive symptoms and frequently cause substantial side ...
Amit Lalwani,Jon Zdon,Maaike Addicks et al. Amit Lalwani et al.
Digital transformation is increasingly shaping how the Medical Affairs (MA) function generates insights, engages stakeholders, and demonstrates value within the pharmaceutical industry. This article examines how MA professionals can navigat...
Mussa Arvani Mussa Arvani
Regulatory acceleration, expanded reliance on real-world evidence (RWE), and increasing integration of artificial intelligence (AI) into healthcare systems have substantially reshaped expectations placed on Medical Affairs. Accelerated and ...